百令胶囊对慢性乙型肝炎抗肝纤维化的临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Clinical Study on Anti hepatic Fibrosis Effect of Bailing Capsule for the Treatment of Chronic Hepatitis B
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:通过对百令胶囊的临床观察来证实其抗纤维化的疗效。方法:采用随机、平行、阳性药对照观察,治疗组30例服用百令胶囊,对照组30例服用大黄虫丸,疗程3个月。结果:治疗组的显效率、总有效率分别为2667%、7334%,对照组为2333%、6333%。结论:百令胶囊通过调节细胞免疫,能明显改善慢性乙型肝炎患者的肝纤维化指标,起到抗纤维化的作用。

    Abstract:

    To confirm the therapeutic effect of Bailing Capsule in resisting liver fibrosis of patients of chronic hepatitis B by clinical observation.Methods:The observation was designed by random,parallel and contrasted positive drug.The treatment group contained 30 cases that were given Bailing Capsule;the control group contained 30 cases that were given Dahuang Zhechong Wan (Dahuang Zhechong pills).The course of the treatment lasted for 3 months.Results:The significant effective rate and the total effective rate of the treatment group were 26.67% and 73.34% respectively.The significant effective rate and the total effective rate of the control group were 23.33% and 63.33% respectively.Conclusion:Bailing Capsule can improve the indexes of liver fibrosis of the patients of chronic hepatitis B by adjusting cell immunity;it has the effect of resisting fibrosis.

    参考文献
    相似文献
    引证文献
引用本文

张玮 邢练军 季光 王奕.百令胶囊对慢性乙型肝炎抗肝纤维化的临床研究[J].世界中医药,2007,2(1).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2006-09-28
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2012-11-09
  • 出版日期:
文章二维码